Estimating the completeness of prevalence based on cancer registry data.
about
Cancer prevalence estimates based on tumour registry data in the Surveillance, Epidemiology, and End Results (SEER) Program.Estimating the prevalence of hematological malignancies and precursor conditions using data from Haematological Malignancy Research Network (HMRN).Estimation and projections of cancer prevalence from cancer registry data.How many people have had a myocardial infarction? Prevalence estimated using historical hospital data.Getting cancer prevalence right: using state cancer registry data to estimate cancer survivors.Estimating and comparing incidence and prevalence of chronic diseases by combining GP registry data: the role of uncertaintyOvarian Cancer Incidence Corrected for Oophorectomy.Prevalence of breast carcinoma in situ in the United States.Estimating the number of colorectal cancer patients treated with anti-tumour therapy in 2015: the analysis of the Czech National Cancer Registry.Long-term survival, prevalence, and cure of cancer: a population-based estimation for 818 902 Italian patients and 26 cancer typesModeling delay to diagnosis for amyotrophic lateral sclerosis: under reporting and incidence estimatesMeasuring cancer prevalence in Europe: the EUROPREVAL project.The increase in cancer prevalence and hospital burden in Western Australia, 1992-2011.Comparison of non-myeloablative conditioning regimens for lymphoproliferative disorders.Complete prevalence of malignant primary brain tumors registry data in the United States compared with other common cancers, 2010.Projections of cancer prevalence in the United Kingdom, 2010-2040Cancer prevalence in the United Kingdom: estimates for 2008.Improved population-based probability of developing cancer when direct estimates of the cancer-free population are available.Two approaches for estimating disease prevalence from population-based registries of incidence and total mortality.Prevalence of multiple malignancies in the Netherlands in 2007.Cancer prevalence in Italy: an analysis of geographic variability.Characteristics of people living in Italy after a cancer diagnosis in 2010 and projections to 2020.Increasing 'active prevalence' of cancer in Western Australia and its implications for health services.Peak and decline in cancer incidence, mortality, and prevalence at old ages.Cancer prevalence in European registry areasContrasts in cancer prevalence in Connecticut, Iowa, and Utah
P2860
Q30596445-B5090007-6B5D-49F0-A10F-636F78E5C2B8Q31111112-21487A28-4642-41F9-877F-1DDA27056654Q33185030-2D1E5592-A5E9-4CD0-9B44-B588412E1622Q33291608-FA705155-DC57-4835-B486-3B0862D79A45Q33832415-1B54DB8F-CE23-42A7-AB84-C312A7D40E6CQ33846637-E2B1CA64-EBF2-4A96-85C5-CFD309CC1262Q33850454-6DBE61DF-809E-4144-9CB3-417B0AD21674Q33908894-A58466C5-5819-4091-89B0-B56699F6C919Q34156439-8E29FB39-78F8-4336-ABB3-F4757F95D540Q34395344-3E3B7CF1-7C80-4527-8EF6-F086163BC42CQ34520051-0969BE40-E934-4602-A004-F02B185E625CQ34746939-27AD45FD-31EC-43EB-B9F2-43A386899A79Q34986518-75ECE975-67C9-4EA0-BA15-C9A79A70BE91Q35151998-C334FC8E-317E-4398-BCA3-373DEA255371Q36236776-2203C612-61F1-47AF-AB26-E8025495F563Q36287990-81CC4DED-CD97-4DB7-A8CF-FA2A8867826CQ37287541-C0B72C7A-AE17-4319-828E-78736A55DDF5Q37995097-855DD107-4E4A-4027-B099-13195A62838AQ38493623-2C42EE75-19A1-4085-A6B8-B3D77F25B4E4Q44127734-0ECAB29C-CE0F-4BA2-B1FF-A7073B3EB127Q44886129-1CF14C68-F1BA-451E-89CD-F30F1BE4C311Q49247245-E0E086D1-79E2-40BB-8476-31BC8B193E4FQ50696651-BC7DD717-52BB-43AB-86ED-E114F98E7369Q53281111-C7DF8425-2220-42CE-B172-A1110D5E6789Q57037907-5BCEEAE4-35E6-4E5B-9A8A-3502DCA8F99EQ57037921-03468827-8F21-4241-A6CF-F4BEF4B30ABB
P2860
Estimating the completeness of prevalence based on cancer registry data.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Estimating the completeness of prevalence based on cancer registry data.
@en
type
label
Estimating the completeness of prevalence based on cancer registry data.
@en
prefLabel
Estimating the completeness of prevalence based on cancer registry data.
@en
P1476
Estimating the completeness of prevalence based on cancer registry data.
@en
P2093
Capocaccia R
De Angelis R
P304
P356
10.1002/(SICI)1097-0258(19970228)16:4<425::AID-SIM414>3.0.CO;2-Z
P407
P577
1997-02-01T00:00:00Z